Apr 30, 2025 (Stock Traders Daily via COMTEX) --
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in Apellis Pharmaceuticals Inc. (NASDAQ: APLS) with integrated risk controls.
Warning:
The trading plans were valid at the time this was published, but the support and resistance levels for APLS change as time passes, and this should be updated in real time. Access those real time updates for this and 1000 other stocks here. Unlimited Real Time Reports
Protection from Market Crashes: Subscribers also get our Tail Risk hedge, Evitar Corte
Instructions:
Use the basic rules of Technical Analysis. Here are some examples: if APLS is testing support the signal is to buy and target resistance. On the other hand, if resistance is tested, that is a sign to short, and target support. No matter which side the trade is, long or short, the trigger point is both a place to enter and as a risk control.
Swing Trades, Day Trades, and Longer term Trading Plans:
This data can be used to define Day Trading, Swing Trading, and Long Term Investing plans for APLS too. All of these are offered here: Access our Real Time Trading Plans
Longer Term Trading Plans for APLS
- Buy APLS near 17.86 target 21.89 stop loss @ 17.81
- Short APLS slightly under 21.89, target 17.86, stop loss @ 21.95
Swing Trading Plans for APLS
- Buy APLS slightly over 21.89, target 26.22, Stop Loss @ 21.83
- Short APLS slightly near 21.89, target 17.9, Stop Loss @ 21.95.
Day Trading Plans for APLS
- Buy APLS slightly over 18.33, target 21.89, Stop Loss @ 18.29
- Short APLS slightly near 18.33, target 17.9, Stop Loss @ 18.37.
APLS Technical Summary | Raw Data for the Trading Plans
Term → | Near |
Mid |
Long |
Bias |
Strong |
Weak |
Weak |
P1 |
0 |
0 |
17.86 |
P2 |
17.67 |
16.91 |
21.89 |
P3 |
18.33 |
17.9 |
26.22 |
%2520Pivots%2520Trading%2520Plans%2520and%2520Risk%2520Controls)
COMTEX_465058586/2570/2025-04-30T01:06:12